OPIANT PHARMACEUTICALS, INC. Contracts & Agreements

102 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Capacity Investment Agreement between Aptar Group Inc. and Opiant Pharmaceuticals, Inc. dated June 8, 2022
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
2022
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2022
2021 Inducement Equity Incentive Plan, as amended on December 9, 2021
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
2021
2021 Inducement Equity Incentive Plan and Form of Option Agreement
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2021
Director Agreement, effective March 18, 2021, by and between Opiant Pharmaceuticals, Inc. and Dr. Lorianne Masuoka
OPIANT PHARMACEUTICALS, INC.
2021
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2021
Amendment of Solicitation/Modification of Contract
OPIANT PHARMACEUTICALS, INC.
2020
Note Purchase and Security Agreement, dated December 10, 2020, by and among Opiant Pharmaceuticals, Inc. and the parties named therein
Note Agreements
OPIANT PHARMACEUTICALS, INC.
2020
Registration Rights Agreement, dated December 10, 2020, by and among Opiant Pharmaceuticals, Inc. and the parties named therein
Registration Rights Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Press Release of Opiant Press Release of Opiant Pharmaceuticals, Inc., dated November 12, 2020, Inc., dated November 12, 2020
Release Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Master Services Agreement dated October 26, 2020 between the Company and AptarGroup, Inc
Services Agreements
OPIANT PHARMACEUTICALS, INC.
2020
Master Services Agreement dated July 1, 2020 and Project Scope Agreement dated July 22, 2020 between the Company and Summit Biosciences, Inc
Services Agreements
OPIANT PHARMACEUTICALS, INC.
2020
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Open Market Sale AgreementSM, dated November 14, 2019, by and between Opiant Pharmaceuticals, Inc. and Jefferies LLC
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Amendment No. 2 to License Agreement, dated March 18, 2019, by and between Registrant and Adapt Pharma Operations Limited
License Agreements
OPIANT PHARMACEUTICALS, INC.
2019
License Agreement between the Company and Sanofi dated December 21, 2018
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Contract between the Company and Biomedical Advanced Research and Development Authority dated September 19, 2018
Development Agreements
OPIANT PHARMACEUTICALS, INC.
2018
Director Agreement, effective October 29, 2018, by and between Opiant Pharmaceuticals, Inc. and Craig A. Collard
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
Underwriting Agreement, dated as of September 25, 2018, by and between Opiant Pharmaceuticals, Inc. and Cantor Fitzgerald & Co
Underwriting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Contract between the Company and Biomedical Advanced Research and Development Authority dated September 19, 2018
Development Agreements
OPIANT PHARMACEUTICALS, INC.
2018
Development and Manufacturing Agreement between the Company and Aesica Queensborough Limited dated September 7, 2018
Development Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Agreement for Reimbursement of Capital Expenditures and Service Fees between the Company and Aesica Queensborough Limited dated September 7, 2018
Services Agreements
OPIANT PHARMACEUTICALS, INC.
2018
Director Agreement, effective June 12, 2018, by and between Opiant Pharmaceuticals, Inc. and Richard Daly
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
License Agreement between the Company and Adapt Pharma Operations Limited, dated as of December 15, 2014
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Executive Employment Agreement, dated January 11, 2018, by and between Dr. Roger Crystal and Opiant Pharmaceuticals, Inc
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Executive Employment Agreement, dated January 11, 2018, by and between Mr. David OToole and Opiant Pharmaceuticals, Inc
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
2018
Executive Employment Agreement, dated January 11, 2018, by and between Dr. Phil Skolnick and Opiant Pharmaceuticals, Inc
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
2018
Forms of Incentive Stock Option Notice and Incentive Stock Option Agreement under the Opiant Pharmaceuticals, Inc. 2017 Long-Term Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2017
Forms of Nonstatutory Stock Option Notice and Nonstatutory Stock Option Agreement under the Opiant Pharmaceuticals, Inc. 2017 Long-Term Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
2017
Form of Restricted Stock Agreement under the Opiant Pharmaceuticals, Inc. 2017 Long-Term Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
2017
License Agreement, dated as of June 22, 2017, by and between the Company and Aegis Therapeutics, LLC
License Agreements
OPIANT PHARMACEUTICALS, INC.
2017
Supply Agreement, dated as of June 22, 2017, by and between the Company and Aegis Therapeutics, LLC
Supply Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Research and Development Agreement, dated as of July 14, 2017, by and between the Company and Renaissance Lakewood, LLC
Development Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Separation Agreement and General Release, dated as of September 5, 2017, by and between the Company and Kevin Pollack
Separation Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2017
Opiant Pharmaceuticals, Inc. 2017 Long-Term Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2017
Agreement and Plan of Merger, dated October 2, 2017, by and between Opiant Pharmaceuticals, Inc., a Nevada corporation, and Opiant Pharmaceuticals, Inc., a Delaware corporation
Merger Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2017
Supplemental Engagement Letter, dated September 8, 2017, by and between the Company and Torreya Partners (Europe) LLP
OPIANT PHARMACEUTICALS, INC.
2017
Sublease, effective as of August 1, 2017, by and between Opiant Pharmaceuticals, Inc. and Standish Management, LLC, as amended by that certain letter agreement, dated as of August...
Lease Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Offer Letter, dated August 29, 2017, by and between the Company and David OToole
OPIANT PHARMACEUTICALS, INC.
2017
THIRD AMENDMENT TO SENIOR ADVISOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
2017
AMENDMENT TO INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
AMENDMENT TO AMENDED AND RESTATED CONSULTINGAGREEMENT
OPIANT PHARMACEUTICALS, INC.
2017
LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15, 2014
License Agreements
OPIANT PHARMACEUTICALS, INC.
2017
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
AMENDMENT TO INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
2017
Employment Agreement Acknowledgement
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Employment Agreement Acknowledgement
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
PURCHASE AND SALE AGREEMENT dated as of December 13, 2016 between OPIANT PHARMACEUTICALS, INC. and SWKFunding LLC
Purchase Agreements
OPIANT PHARMACEUTICALS, INC.
2017
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
THIRD AMENDMENT TO SENIOR ADVISOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Senior Advisor Agreement
OPIANT PHARMACEUTICALS, INC.
2017
First Amendment toSenior Advisor Agreement
OPIANT PHARMACEUTICALS, INC.
2017
SecondAmendment to Senior Advisor Agreement
OPIANT PHARMACEUTICALS, INC.
2017
Employment Agreement
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
2017
OPIANT PHARMACEUTICALS, INC. DIRECTOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London,W1U 6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
AMENDED AND RESTATED CONSULTING AGREEMENT
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London, W1U6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
AMENDED AND RESTATEDINTEREST AGREEMENT
OPIANT PHARMACEUTICALS, INC.
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London,W1U 6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London, W1U6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
2016
INVESTMENT AGREEMENT
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
AMENDED AND RESTATED INTEREST AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
REGULATORY AND STRATEGIC ADVISOR CONSULTANCYAGREEMENT
OPIANT PHARMACEUTICALS, INC.
2016
Torreya Partners (Europe) LLP isauthorised and regulated by the Financial Conduct Authority.
OPIANT PHARMACEUTICALS, INC.
2016
AMENDED AND RESTATED MATERIAL TRANSFER, OPTION AND RESEARCHLICENSE AGREEMENT between OPIANT PHARMACEUTICALS, INC. and AEGIS THERAPEUTICS, LLC
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
11770 Bernardo Plaza Court, Suite 353 San Diego, CA 92128 Phone: 858 ###-###-#### Facsimile ###-###-#### Confidential
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2016
OPIANTPHARMACEUTICALS, LNC. DIRECTORAGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
OPIANT PHARMACEUTICALS, INC. DIRECTOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Employment Agreement
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
2016
Third Amendment to Executive Letter ofReappointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Executive Letter ofAppointment
OPIANT PHARMACEUTICALS, INC.
2016
LIGHTLAKETHERAPEUTICS INC. 445Park Avenue, 9th Floor NewYork, NY STOCKOPTION GRANT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
LIGHTLAKETHERAPEUTICS INC. 445Park Avenue, 9th Floor NewYork, NY STOCKOPTION GRANT
OPIANT PHARMACEUTICALS, INC.
2015
LIGHTLAKETHERAPEUTICS INC. 445Park Avenue, 9th Floor NewYork, NY STOCKOPTION GRANT
OPIANT PHARMACEUTICALS, INC.
2015
LIGHTLAKE THERAPEUTICS INC. 445 Park Avenue, 9th Floor New York, NY STOCK OPTION GRANT
Stock Agreements
OPIANT PHARMACEUTICALS, INC.
2015
LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15, 2014
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2015
MATERIAL TRANSFER, OPTION AND RESEARCHLICENSE AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Confidential AMENDMENTNO. 2 TOTHE MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENT EFFECTIVEAS OF DECEMBER 1, 2014
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15 2014
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2015
ConfidentialTreatment Requested by Lightlake Therapeutics Inc. IRS EmployerIdentification No. 46 ###-###-#### Confidentialtreatment requested with respect to certain portions...
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
LICENSE AGREEMENT between LIGHTLAKETHERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15 2014
License Agreements
OPIANT PHARMACEUTICALS, INC.
2015
MATERIAL TRANSFER, OPTION AND RESEARCHLICENSE AGREEMENT
OPIANT PHARMACEUTICALS, INC.
2015
Second Amendment to Employment Agreement
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Second Amendment to Executive Letterof Reappointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Second Amendment to Executive Letterof Appointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Amendment to Employment Agreement
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
2013
Amendment to Executive Letter of Reappointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013
Amendment to Executive Letter of Appointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013
Director Agreement
OPIANT PHARMACEUTICALS, INC.
2013
COMMONSTOCK PURCHASE AGREEMENT Privateand Confidential
Purchase Agreements
OPIANT PHARMACEUTICALS, INC.
2009
MADRONAVENTURES, INC. PURCHASEAGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2009
METHODFOR TREATING EATING DISORDERS BYSELECTIVE EXTINCTION WITH TRANSDERMAL NALOXONE Inventor:John David Sinclair,Vilniementie 4K42, FIN 02940 Espoo, Finland
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2009
(19) [EUROPEAN PATENT OFFICE LOGO] [BAR CODE] (11)EP 1 681 057 B1
OPIANT PHARMACEUTICALS, INC.
2009